SHPG - Shire plc

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by fthree, Aug 4, 2016.

  1. fthree

    fthree Member

    Joined:
    Apr 10, 2016
    Messages:
    63
    Likes Received:
    8
    [​IMG]
    Shire plc (SHPG) is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. The Company's products include VYVANSE/VENVANSE/ELVANSE/TYVENSE/ELVANSEVUXEN/ADUVANZ (lisdexamfetamine dimesylate), ADDERALL XR (mixed salts of a single-entity amphetamine), INTUNIV (extended release guanfacine), LIALDA (mesalamine)/MEZAVANT(mesalazine), PENTASA (mesalamine), REPLAGAL (agalsidase alfa), ELAPRASE (idursulfase), VPRIV (velaglucerase alfa), FIRAZYR (icatibant), FOSRENOL (lanthanum carbonate), KALBITOR, CINRYZE C1 esterase inhibitor (human), GATTEX/REVESTIVE, BUMINATE 25% Albumin (Human), BUMINATE 5% Albumin (Human), GLASSIA Alpha1-Proteinase Inhibitor (Human) and ONCASPAR pegaspargase.

    --------------

    Looking at the charts for them they look like a pretty solid company with good returns. Suffered from the same losses that the other bio tech companies did but seems to be rebounding and able to preform into the future. Thoughts?
     
    #1 fthree, Aug 4, 2016
    Last edited by a moderator: Aug 4, 2016
  2. fthree

    fthree Member

    Joined:
    Apr 10, 2016
    Messages:
    63
    Likes Received:
    8
    WOW thanks for the edit! looks great
     

Share This Page